Efficient Value of Information Calculation Using a Nonparametric Regression Approach: An Applied Perspective by Tuffaha, H.W. et al.
This is an author produced version of Efficient Value of Information Calculation Using a 
Nonparametric Regression Approach: An Applied Perspective.
White Rose Research Online URL for this paper:
http://eprints.whiterose.ac.uk/98315/
Article:
Tuffaha, H.W., Strong, M. orcid.org/0000-0003-1486-8233, Gordon, L.G. et al. (1 more 
author) (2016) Efficient Value of Information Calculation Using a Nonparametric 
Regression Approach: An Applied Perspective. Value in Health, 19 (4). pp. 505-509. ISSN 
1098-3015 
https://doi.org/10.1016/j.jval.2016.01.011
Article available under the terms of the CC-BY-NC-ND licence 
(https://creativecommons.org/licenses/by-nc-nd/4.0/)
promoting access to
White Rose research papers
eprints@whiterose.ac.uk
http://eprints.whiterose.ac.uk/
1 
 
Efficient value of information calculation using a non-parametric regression approach: 
an applied perspective 
 
Haitham W Tuffaha*1,2, Mark Strong3, Louisa G Gordon1,2,  Paul A Scuffham1,2 
 
Affiliations 
1. Menzies Health Institute Queensland, Griffith University, Gold Coast, QLD Australia.  
2. Centre for Applied Health Economics, School of Medicine, Griffith University, 
Meadowbrook QLD, Australia. 
3.  School of Health and related Research (ScHARR), University of Sheffield, Sheffield, 
UK. 
 
*Corresponding Author contact details  
Centre for Applied Health Economics, School of Medicine, Griffith University, QLD, 
Australia 
haitham.tuffaha@griffith.edu.au 
Tel: 61 7 338 21510 
Fax: 61 7 338 21338 
 
Key words 
 
Value of information, non-parametric regression, Monte Carlo simulation 
 
 
Acknowledgment  
Haitham Tuffaha is supported by a National Health and Medical Research Council PhD 
scholarship through the Centre for Research Excellence in Nursing Interventions for 
2 
 
Hospitalised Patients. 
Mark Strong is supported by a post-doctoral National Institute for Health Research 
fellowship. This report is independent research supported by the UK National Institute for 
Health Research (Post-Doctoral Fellowship, PDF-2012-05-258). The views expressed in this 
publication are those of the author(s) and not necessarily those of the NHS, the National 
Institute for Health Research or the Department of Health. 
 
Conflict of interest 
 
The authors declare no conflict of interest. 
  
3 
 
Efficient value of information calculation using a non-parametric regression approach: 
an applied perspective 
Abstract 
Value of information (VOI) analysis provides an analytical framework to assess whether 
obtaining additional evidence is worthwhile to reduce decision uncertainty. The reporting of VOI 
measures, particularly, the expected value of perfect parameter information (EVPPI) and the 
expected value of sample information (EVSI), is limited because of the computational burden 
associated with typical two-level Monte Carlo-based solution. Recently, a non-parametric 
regression approach was proposed that allows the estimation of multi-parameter EVPPI and EVSI 
directly from a probabilistic sensitivity analysis sample. We used the regression approach to 
calculate EVPPI and EVSI in two models, and compared the results with the estimates obtained 
via standard Monte Carlo simulation. VOI values from the two approaches were very close; 
however, the regression method was faster. We conclude that the non-parametric regression-
based approach provides an efficient and easy-to-implement alternative for EVPPI and EVSI 
calculation in economic models. 
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1. Introduction 
Decision models are commonly used to evaluate the cost-effectiveness of health 
interventions. They are populated with input parameters estimated from various sources; 
however, the true values of these parameters are not known with certainty, which may result 
in suboptimal decisions.(1) The preferred approach to characterise decision uncertainty is to 
conduct probabilistic sensitivity analysis (PSA) whereby uncertainty is propagated in the 
model using Monte Carlo simulation.(2) Decision uncertainty is then presented as the 
probability that each intervention has the highest expected net benefit (i.e., benefits minus 
costs). Nevertheless, an important additional step is to know whether a decision can be made 
based on current evidence or if additional research is required. This can be informed using 
value of information (VOI) analysis.(3) Measures of VOI include (1) the expected value of 
perfect information (EVPI), which is the maximum value of additional information to resolve 
all uncertainty in the parameters; (2) the expected value of perfect parameter information 
(EVPPI), which is the value of resolving uncertainty in a given parameter or set of 
parameters; and (3) the expected value of sample information (EVSI), which estimates the 
value of a particular data collection exercise (e.g. a randomised controlled trial with some 
chosen sample size) in reducing decision uncertainty.(4)  
EVPI calculation is straightforward given the PSA; however, although this measure is 
necessary, it is not sufficient to inform decisions because it represents only an upper-bound of 
the value of additional research to resolve uncertainty.(3) Rather, it is important to know 
which parameters are contributing most to decision uncertainty, such that further research 
should focus on these. Here, the EVPPI for some parameter represents the value of 
eliminating uncertainty about that parameter, and therefore gives an upper-bound on the 
value of a study to inform that parameter. The EVSI meanwhile represents the value of a 
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given study design in reducing parameter uncertainty.(5) Comparing the EVSI with the 
expected cost of a research study establishes a sufficient condition to inform whether 
additional research is worthwhile. Unfortunately, the reporting of EVSI and EVPPI estimates 
in economic evaluations remains limited because of the perceived computational burden 
associated with these two measures.(6-8)  
The EVPPI for a single parameter or a group of parameters is typically calculated 
using a two-level nested Monte Carlo simulation approach. This requires sampling values of 
the parameter(s) of interest in an outer loop, and then conditional on each sampled parameter 
set, sampling from the joint conditional distribution of the remaining parameters in an inner 
loop. At each inner loop step the model is evaluated.(9, 10) For EVSI calculation, plausible 
sets of data from the proposed future study of a given sample size are simulated in an outer 
loop, and then conditional on each generated data set, the posterior distribution of the 
parameters is sampled in an inner loop. Again, the model is evaluated at each inner loop 
step.(11, 12) The repeated sampling and evaluation of the model within the inner loop is time 
consuming. Calculating EVSI values for a range of possible sample sizes could take days or 
even weeks depending on the complexity of the model.(12-14) Furthermore, it is often 
difficult to determine the number of simulations at each level to ensure adequate precision 
and to avoid the upward bias that results from the maximisation over sampled quantities that 
occurs within the outer loop of the simulation.(15) Finally, the presence of parameter 
correlation or non-conjugacy between prior parameter distributions and proposed data 
likelihoods makes EVSI calculation even more difficult.(11) Here, Markov Chain Monte 
Carlo simulation (or some similar approach) will be necessary.(6, 7) In some situations, most 
notably in multi-linear (i.e. sum-product type) models (e.g., decision tree) where the net 
benefit is a linear function of the cost and effect parameters, or when the incremental net 
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benefit is approximately normally distributed, one-level Monte Carlo simulation or analytical 
equations can be used.(11, 16, 17) However, there is a wide class of models for which these 
constraints do not apply.  
Methods for efficient EVPPI calculation of single parameters have been developed. 
These show promise, but do not extend to groups of parameters simultaneously.(18, 19) A 
method based on the numerical approximation of the posterior expected net benefit, 
conditional on sampled data, has been proposed as an efficient approach for EVSI 
calculation; however, it requires significant skills and effort to write the necessary computer 
code.(13, 20) Recently, Strong et al. have proposed a more straightforward non-parametric 
regression approach for calculating multi-parameter EVPPI and EVSI directly from a PSA 
sample.(9, 21) The method has the advantage in that the model does not need to be run as part 
of the EVPPI or EVSI algorithm. Nevertheless, there is a need to demonstrate the value of 
this method in real-world cases and to compare its performance with the standard approach of 
Monte Carlo simulation. 
    In this paper we apply the non-parametric regression method to calculate the EVPPI 
and the EVSI in two decision models for two healthcare interventions. In addition, we 
compare the results and computation time with the estimates obtained using Monte Carlo 
simulation.  
2. Methods 
2.1 The two economic models 
We conducted two cost-effectiveness analyses using two decision models constructed 
in TreeAge Pro (Version 2014 R1). The full details of the two models and analyses can be 
found elsewhere.(22, 23)  
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Model 1: Negative pressure wound therapy in caesarean section patients 
The first model was a decision tree for negative pressure wound therapy (NPWT) 
compared with hydrocolloid dressing in preventing surgical site infections following 
caesarean sections in high-risk (e.g., obese) women.(23) The modelled patients may develop 
surgical site infection which could be either superficial or deep. Patients could die or survive 
depending on the type of the infection developed (Appendix 1). To populate the model we 
systematically searched the literature and identified relevant evidence. Due to the scarcity of 
information on the effectiveness of NPWT in this setting, we combined the data on the 
relative effectiveness of the device from a pilot study (n=92) on obese women undergoing 
caesarean sections with the data from a trial (n=81) on NPWT in high-risk patients with 
various types of surgeries.(23) 
 
Model 2: Nutritional support for the prevention of pressure ulcers in hospitalized patients 
The second model was a six-health-state Markov cohort model for nutritional support 
compared with standard hospital diet in preventing pressure ulcers.(22) Model duration was 
one year with a one-day cycle length. Patients start the model with intact skin before they 
move sequentially between different stages of skin ulceration (i.e., closed wound to open 
wound).  Further, patients could either die of any cause, be discharged, or remain hospitalised 
(Appendix 1). We systematically searched and identified relevant evidence. We performed a 
meta-analysis of five trials (n=1,381) to estimate the relative effectiveness of nutritional 
support in preventing pressure ulcers compared with hospital diet.(22) 
 
The two models were probabilistic; input parameters were assigned probability 
distributions. In general, beta distributions for probabilities and utilities, gamma distributions 
for costs and disutilities, and lognormal distributions for relative risks.(22, 23) For the set of 
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unknown input parameters (ș), each model predicted the net benefit (NB) for each 
intervention (i), thus NB (i, ș willingness-to-pay* Effect (iș± &RVWLș). The efficacy 
outcome in the two models was quality-adjusted life-years (QALYs) gained, and we set the 
willingness-to-pay threshold at $50,000/QALY. The preferred intervention would be the one 
with the maximum expected NB (maxi Eș NB (i, ș). In each case, a PSA was performed 
using Monte Carlo simulation (10,000 iterations) to characterise decision uncertainty. 
2.2 Value of information calculation 
We calculated VOI measures using the standard Monte Carlo and the Strong et al. 
non-parametric regression approach for each of the two decision models. We also recorded, 
for each decision problem, the computation time for each VOI approach.  
Methods to calculate value of information measures using Monte Carlo simulations 
are described in detail elsewhere.(11, 24, 25) In summary, we started our analysis by 
calculating the EVPI, which is the difference between the expected NB of a decision with 
perfect information and the decision based on current information:(3) 
EVPI = Eș maxi 1%Lș- maxi Eș 1%Lș    Equation 1  
The EVPPI for the parameter(s) of interest șI is the difference between the expected NB 
with perfect information on these parameters, conditional on the complementary set of other 
parameters șC, and the expected NB with current information: (5, 25) ࡱࢂࡼࡼࡵࣂࡵ  ൌ  ࡱࣂࡵ࢓ࢇ࢞࢏ࡱሺࣂ࡯ȁࣂࡵሻࡺ࡮ሺ࢏ǡ ࣂࡵǡ ࣂ࡯ሻ െ ࢓ࢇ࢞࢏ࡱࣂࡺ࡮ሺ࢏ǡ ࣂሻ  Equation 2
 
For the pressure ulcer Markov model, we performed two nested Monte Carlo simulation 
procedures with 1,000 simulations in each loop. We found this number of simulations 
sufficient for the estimates to converge.(25) We assumed the NPWT model is linear with no 
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correlation between input parameters, and therefore, a one-level simulation scheme was used 
in which we sampled from șI, but kept șC fixed at their prior mean.(25)  
The EVSI is the difference between the expected value of a decision made after 
collecting data (D) on the parameter(s) of interest and the expected NB with current 
information:(11) ࡱࢂࡿࡵ ൌ ࡱࡰ࢓ࢇ࢞࢏ࡱࣂ࡯ǡࣂࡵȁࡰࡺ࡮ሺ࢏ǡ ࣂࡵǡ ࣂ࡯ሻ െ ࢓ࢇ࢞࢏ࡱࣂࡺ࡮ሺ࢏ǡ ࣂሻ Equation 3 
We assumed the prior distribution and data were conjugate distributions, and thus, the 
posterior distribution was known in closed form.(11, 14) We conducted a two-level Monte 
Carlo simulation with 1,000 iterations in each of the inner and outer loops for the Markov 
pressure ulcer model.(11) For the NPWT decision tree, we avoided nested simulation in 
estimating the NBs E\³SOXJJLQJLQ´the prior means of șC and the posterior means of șI.(11) 
We repeated EVPPI and EVSI calculations for the two models using regression 
methods in R software as described by Strong et al. (9, 21) Using the PSA sample of 10,000 
iterations (K =10,000), we fitted a regression model for each decision option. After that we 
extracted the regression model fitted values denoted as ො݃൫݅ǡ ߠூ௞൯ and calculated EVPPI via: 
(9) 
ࡱࢂࡼࡼࡵࣂࡵ  ؆  ૚ࡷ  ? ࡷ࢑ୀ૚ ࢓ࢇ࢞࢏ࢍෝ൫࢏ǡ ࣂ࢑ࡵ൯ െ ࢓ࢇ࢞࢏  ૚ࡷ  ? ࡷ࢑ୀ૚ ࢍෝ൫࢏ǡ ࣂࡵ࢑൯ Equation 4 
To calculate EVSI, we generated data and calculated summary statistic Dk conditional on 
each sample ߠ୩୍ in the PSA. For the relative risk parameter for example, we calculated the 
summary statistics by generating a sample data of the probability of the event in the 
intervention group ( ௜ܲ௞) from a Binomial ( ௜ܲ௞, n) and for the control group ( ௖ܲ௞) from a 
Binomial ( ௖ܲ௞, n); thus, Dk = log ( ௜ܲ௞ ௖ܲ௞ ? ሻǤ Then we fitted a regression model for each 
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decision option and extracted the regression model fitted values denoted as ො݃ሺ݅ǡ ܦ௞ሻ. EVSI 
was estimated via:(21)   ࡱࢂࡿࡵ ؆  ૚ࡷ  ? ࡷ࢑ୀ૚ ࢓ࢇ࢞࢏ࢍෝ൫࢏ǡ ࡰ࢑ࡵ൯ െ ࢓ࢇ࢞࢏  ૚ࡷ  ? ࡷ࢑ୀ૚ ࢍෝ൫࢏ǡ ࡰ࢑۷൯  Equation 5 
3. Results 
The incremental NB of NPWT was $70 with 65% probability being cost-effective. 
The per-person EVPI was $76. The parameter with the highest EVPPI was the relative risk of 
surgical site infection. The per-person EVPPI was estimated at $75 using Monte Carlo 
simulation, and $74 using non-parametric regression. The per-person EVSI for a future study 
to inform this parameter was $63 when calculated with Monte Carlo simulation compared 
with $61 using regression. The calculation time for the EVPPI and EVSI measure was short 
(around one minute) in both Monte Carlo simulation and non-parametric regression.  
For nutritional support intervention, the incremental NB was $675 indicating it is 
cost-effective. The probability this intervention is cost-effective was 85%, and the per-person 
EVPI was $33. The parameter with the highest per-person EVPPI value was the relative risk 
of pressure ulcer which had a value of $17 under both methods of computation. The per-
person EVSI of a study to inform this parameter was approximately $6 under both 
approaches. In terms of the computation time, non-parametric regression estimated EVPPI 
and EVSI values in less than one minute and in one step. For the Monte Carlo simulation, 
every EVPPI estimate took around four hours, and every EVSI value for a given sample size 
took around eight hours. Table 1 summarises the results and Figure 1 illustrates the EVSI 
curves from the two models. 
4. Discussion 
This study reports the first comparison of the non-parametric regression and Monte 
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Carlo methods for EVPPI and EVSI computation in real-life decision problems. The 
estimates from the two methods were close; however, VOI computation using regression 
methods was faster, particularly in the Markov model. The regression approach eliminated 
the need for two-level simulation in the Markov model. Further, we avoided the Bayesian 
updating step for EVSI calculation. This benefit of the regression method becomes very 
important in the computation of EVSI when the parameter prior is not conjugate to the data 
likelihood. 
The non-parametric regression method used in this paper represents a significant 
contribution in resolving the computational burden often perceived with EVPPI and EVSI 
calculation. The method provides a flexible approach to calculate VOI measures for models 
built in any software and of any complexity. The approach does not require knowledge of the 
statistics language R, or sophisticated programming ability. Although the R code is provided, 
the Sheffield Accelerated Value of Information (SAVI) online tool provides a free platform 
for VOI calculation.(26) It only requires that the PSA files be uploaded before VOI measures 
can be calculated and presented. We anticipate that the uptake of this efficient approach will 
increase as time passes. This will hopefully encourage more reporting of VOI estimates in 
economic evaluations and encourage a wider adoption of VOI analysis as a useful tool to 
inform funding decisions and to optimise research design and prioritisation. 
It is worth mentioning that another efficient approach has been recently proposed by 
Jalal and Kuntz for EVSI calculation from a PSA sample.(27) In their method, they use linear 
regression metamodeling with the assumption that the incremental NB is normally 
distributed.(27) Unfortunately, the normality assumption, and the assumption of linearity of 
the model could make it difficult to generalise this approach.(28) However, it would be 
interesting to see how the two regression approaches, and other efficient methods, compare 
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using models of various types.  It would be useful also to compare the performance of these 
efficient methods with Monte Carlo simulation using more complex models such as those 
using microsimulation, or models with non-conjugate priors (e.g., Weibull distribution), or 
with correlated parameters.  
In conclusion, the non-parametric regression-based approach provides an efficient, 
flexible and easy-to-implement alternative for EVPPI and EVSI calculation in economic 
models. The approach should facilitate the wider incorporation of VOI analysis in decision 
frameworks.  
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Table 1: A comparison of value of information measures calculation using Monte Carlo 
simulation and non-prametric regression 
Intervention EVPPI in $  (SE) Approximate 
computation  
time 
EVSI in $  
(SE)c 
Approximate 
computation  
time 
Monte Carlo simulationa 
NPWT RR site infection:   
Other parameters: 
74.8 (1.6) 
3.0 (0.3) 
1 minute 
1 minute 
63.0 (1.3) 1 minute 
Nutritional 
support  
RR pressure ulcer: 
Other parameters:   
17.4 (2.2) 
8.9 (1.7) 
4 hours 
4 hours 
6.4 (0.7) 8 hours 
Non-parametric regressionb 
NPWT RR site infection:   
Other parameters: 
74.3 (0.6) 
5.8 (1.4) 
1 minute 
1 minute 
61.2 (0.8) 1 minute 
 
Nutritional 
support  
RR pressure ulcer: 
Other parameters:   
17.2 (1.0) 
9.4 (1.0) 
1 minute 
1 minute 
6.3 (0.8) 1 minute 
 
a Two-level Monte Carlo of 1,000 iterations each in the nutritional support model, and single level simulation of 
10,000 iterations in the NPWT model. 
b
 From a probabilistic sensitivity sample of 10,000 iterations. 
c For a sample size of 200 patients in the NPWT model and 1,200 patients in the nutritional support model. 
$ = Australian dollar; NPWT = negative pressure wound therapy; EVPI = expected value of perfect information; 
EVPPI = expected value of perfect parameter information; EVSI = expected value of sample information; RR = 
relative risk; SE = standard error. 
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EVSI = Expected value of sample information; MS = Monte Carlo simulation 
 
Figure 1: EVSI curves for the nutritional support model (A) and NPWT model (B) 
 
